Skip to content
EvidenceHelixEvidenceLib · Scientific Encyclopedia
⌘ K

Scientific library

EvidenceLib encyclopediaAll articles A–Z2,835Open textbooks209Open-access articles1,406Cancer study catalog458How it is made

My workspace this browser

Saved pages0Notes & annotations0

Recently viewed

Explore by field

Cancer and Oncology182Genetics and Genomics170Neuroscience185Cardiovascular Medicine180Immunology142Pharmacology173Molecular Biology161Infectious Diseases150Rare and Inherited Diseases181Clinical Research173Anatomy and Physiology613Drugs and Chemicals621Psychiatry and Psychology185Public Health and Nutrition178Diagnostics and Medical Technology125Respiratory Medicine113Digestive System and Liver91Metabolism and Endocrine Disease177Bones, Joints, Muscles and Skin213Kidney, Urology and Women's Health173Eye, Ear, Nose and Throat55
Plans & pricingCompare EvidenceHelix workspace plans
Library›Open textbooks›Methylphenidate versus placebo for fatigue in patients with advanced cancer: the MePFAC randomised controlled trial

EvidenceLib · Open textbook · CC BY 4.0

Methylphenidate versus placebo for fatigue in patients with advanced cancer: the MePFAC randomised controlled trial

Patrick Stone, Ollie Minton, Alison Richardson, Peter Buckle, Zinat E Enayat, Louise Marston, Nick Freemantle · 11 sections in 11 chapters. Each section is its own page.

Synopsis

  • Synopsis

Discussion

  • Discussion

Patient and public involvement

  • Patient and public involvement

Equity, diversity and inclusion

  • Equity, diversity and inclusion

Impact and learning

  • Impact and learning

Implication for decision-makers

  • Implication for decision-makers

Research recommendations

  • Research recommendations

Conclusions

  • Conclusions

References

  • References

Additional information

  • Additional information

List of supplementary material

  • List of supplementary material

Attribution. Patrick Stone; Ollie Minton; Alison Richardson; Peter Buckle; Zinat E Enayat; Louise Marston et al. (2025). Methylphenidate versus placebo for fatigue in patients with advanced cancer: the MePFAC randomised controlled trial. National Institute for Health and Care Research. Copyright © 2025 Stone et al. Licensed under CC BY 4.0. NCBI Bookshelf NBK616759. CC BY 4.0. Original source ↗. Text reproduced from the Bookshelf XML without changing wording; figures, images and supplements are not reproduced.

About this book

Publisher
National Institute for Health and Care Research
Licence
CC BY 4.0
Sections
11
Year
2025
Words
15,655
Retrieved
2026-11-04

Source record on NCBI Bookshelf ↗

EvidenceLib is a research-education resource, not medical advice. It does not diagnose, prescribe or recommend starting, stopping or changing any treatment. Talk to a qualified clinician about your own situation. Methods, sources and licences · Rights and removal requests · Legal · Support